CEO reflects on 2025, when Acorai validated its non-invasive technology in the 1,600-patient CAPTURE-HF…
CEO reflects on 2025, when Acorai validated its non-invasive technology in the 1,600-patient CAPTURE-HF study, launched a next-gen device, expanded IP, and grew global traction…